Galacto-oligosaccharide-containing composition and a method of producing it
US-2016369313-A1 · Dec 22, 2016 · US
US2023279456A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2023279456-A1 |
| Application number | US-202218061585-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 5, 2022 |
| Priority date | Apr 25, 2021 |
| Publication date | Sep 7, 2023 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure discloses genetically engineered bacteria producing lacto-N-neotetraose and a production method thereof, and belongs to the fields of metabolic engineering and food biotechnology. To solve the problem of low yield of lacto-N-neotetraose produced by a microbial method in the prior art, through exogenous expression of lgtA and lgtB, reasonable combination and regulation of overexpression of lacY, pgm, galE, galT and galK in a lacto-N-neotetraose synthesis pathway, knockout of lacZ expression in an Escherichia coli host, and optimization of a carbon source in the culture process, the disclosure achieves the objectives of regulating the carbon flux of a metabolic pathway and improving the yield of lacto-N-neotetraose. In a shake flask experiment, the yield of lacto-N-neotetraose produced by E. coli increased from 304 mg/L to 1031 mg/L, laying a foundation for industrial production of the lacto-N-neotetraose.
Opening claim text (preview).
1 . Genetically engineered bacteria producing lacto-N-neotetraose, wherein in the genetically engineered bacteria, β-galactosidase gene lacZ is knocked out, and β-1,3-acetylglucosamine transferase gene lgtA, β-1,4-galactosyltransferase gene lgtB, phosphoglucomutase gene pgm, UDP-glucose-4-epimerase gene galE, galactose-1-phosphate uridyltransferase gene galT, galactokinase gene galK and β-galactoside permease gene lacY are overexpressed. 2 . The genetically engineered bacteria according to claim 1 , wherein the β-1,3-acetylglucosamine transferase gene lgtA and β-1,4-galactosyltransferase gene lgtB are both from Neisseria meningitidis ; the nucleotide sequence of β-1,3-acetylglucosamine transferase gene lgtA is set forth in SEQ ID NO: 1; and the nucleotide sequence of β-1,4-galactosyltransferase gene lgtB is set forth in SEQ ID NO: 2. 3 . The genetically engineered bacteria according to claim 1 , wherein the phosphoglucomutase gene pgm, UDP-glucose-4-epimerase gene galE, galactose-1-phosphate uridyltransferase gene galT, galactokinase gene galK, β-galactoside permease gene lacY and β-galactosidase gene lacZ are all from Escherichia coli K-12; the nucleotide sequence of phosphoglucomutase gene pgm is set forth in SEQ ID NO: 24, the nucleotide sequence of UDP-glucose-4-epimerase gene galE is set forth in SEQ ID NO: 25, the nucleotide sequence of galactose-1-phosphate uridyltransferase gene galT is set forth in SEQ ID NO: 26, the nucleotide sequence of galactokinase gene galK is set forth in SEQ ID NO: 27, the nucleotide sequence of β-galactoside permease gene lacY is set forth in SEQ ID NO: 28, and the nucleotide sequence of β-galactosidase gene lacZ is set forth in SEQ ID NO: 23. 4 . The genetically engineered bacteria according to claim 1 , wherein the genetically engineered bacteria express the gene lacY with pETDuet-1 plasmid, express the genes pgm, galE, galT and galK sequentially with pRSFDuet-1 plasmid, and express the genes lgtA and lgtB sequentially with pCDFDuet-1 plasmid. 5 . A method of use of the genetically engineered bacteria of claim 1 for producing lacto-N-neotetraose, comprising the following steps: (1) culturing the genetically engineered bacteria in a seed medium to obtain a seed solution; (2) inoculating the seed solution into a fermentation system and culturing the seed solution until the OD 600 is 0.6-0.8; and (3) adding IPTG with a final concentration of 0.4 mM and lactose with a final concentration of 8 g/L-10 g/L for performing induction to obtain a fermentation broth containing lacto-N-neotetraose. 6 . The method according to claim 5 , wherein carbon source in the fermentation system is one or more of glucose, galactose and glycerin. 7 . The method according to claim 6 , wherein the carbon source is 20 g/L glycerin, or a mixture of 10 g/L glycerin and 10 g/L galactose; and the fermentation system further contains 13.5 g/L potassium dihydrogen phosphate, 4.0 g/L diammonium hydrogen phosphate, 1.7 g/L citric acid, 1.4 g/L magnesium sulfate heptahydrate and 10 ml/L trace metal elements, the trace metal elements comprising 10 g/L ferrous sulfate, 2.25 g/L zinc sulfate heptahydrate, 1.0 g/L anhydrous copper sulfate and 2.0 g/L calcium chloride dihydrate. 8 . The method according to claim 5 , wherein the seed medium in the method is an LB liquid medium, and the seeds are cultured at 35° C.-40° C. and 200 rpm-250 rpm for 10-14 hours in a shake flask. 9 . The method according to claim 5 , wherein the seed solution is inoculated into the fermentation system and is cultured at 35° C.-40° C. and 200 rpm-250 rpm until the OD 600 is 0.6-0.8, and culture is induced at 22° C.-30° C. and 200 rpm-250 rpm for 42-48 hours.
Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase · CPC title
UDP-glucose--hexose-1-phosphate uridylyltransferase (2.7.7.12) · CPC title
Phosphoglucomutase (5.4.2.2) · CPC title
Nucleotidyltransferases (2.7.7) · CPC title
Hexosyltransferases (2.4.1) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.